1. Tuan H, Kang L, Zhou EY, Chen D, Liu D, Shu D, Bi Z, Zhao Y. Xanthoma disseminatum effectively treated with 2-chlorodeoxyadenosin (cladribine): a Chinese case series and mini review of the literature.Eur J Dermatol. 2019 Oct 1;29(5):538-539.
2. Sun Z, Shi X, Wang Y, Zhao Y. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity. Dermatology. 2018;234(3-4):120-126. doi: 10.1159/000488672.
3. Jin T, Sun Z, Chen X, Wang Y, Li R, Ji S, Zhao Y. Serum Human Beta-Defensin-2 Is a Possible Biomarker for Monitoring Response to JAK Inhibitor in Psoriasis Patients. 2017;233(2-3):164-169. doi: 10.1159/000475809.
4. Zhao Y, Tu P, Zhou G, Zhou Z, Lin X, Yang H, Lu Z, Gao T, Tu Y, Xie H, Zheng Q, Gu Y, Tao J, Zhu X. Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled Trial.PLoS One. 2016 May 26;11(5):e0156219.
5. Zhao Y. Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med. 2016 Feb 25;374(8):789
6. Zhao Y, Li CY, Wen CM, Wei YB, Li RY, Wang G, Tu P. The prevalence of actinic keratoses in the patients visiting dermatologists in two hospitals of China. Br J Dermatol. 2016 May;174(5):1005-10.
7. Zhao Y, Wen CM, Zhou NN, Feng Q, Tu P. 1064-nm Q-switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population. J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2263-5.
8. Zhao Y, Zhang CF, Rossiter H, Eckhart L, König U, Karner S, Mildner M, Bochkov VN, Tschachler E, Gruber F. Autophagy is Induced by UVA and Promotes Removal of Oxidized Phospholipids and Protein Aggregates in Epidermal keratinocytes. J Invest Dermatol. 2013 Jun; 133(6):1629-37
9. Yi Zhao, Jining Tao, Ping Tu. Quantitative evaluation of efficacy of photodynamic therapy for port-wine stains using erythema index image analysis. Photodiagnosis and Photodynamic Therapy, 2013 May;10(2):96-102
10.Zhao Y, Zhou Z, Zhou G, Tu P, Zheng Q, Tao J, Gu Y, Zhu X. Efficacy and safety of hemoporfin in photodynamic therapy for port-wine stain: a multicenter and open-labeled phase IIa study. Photodermatol Photoimmunol Photomed. 2011 Feb;27(1):17-23.
